About Investors Technology Products News Contact Investors Overview We develop, manufacture, license and market quality rapid testing solutions built on our patented Rapid Vertical Flow Technology™. We became public in 2000 and our stock is traded on the TSXV:MIR. Financial Reports 2021 MedMira FY2021 Q1 Financial Statements MedMira FY2021 Q1 MD&A MedMira FY2021 Q2 Financial Statements MedMira FY2021 Q2 MD&A MedMira FY2021 Q3 Financial Statements MedMira FY2021 Q3 MD&A 2020 MedMira FY2020 Q1 Financial Statements MedMira FY2020 Q1 MD&A MedMira FY2020 Q2 Financial Statements MedMira FY2020 Q2 MD&A MedMira FY2020 Q3 Financial Statements MedMira FY2020 Q3 MD&A MedMira FY2020 Q4 and Year End Results MedMira FY2020 MD&A 2019 MedMira FY2019 Q1 Financial Statements MedMira FY2019 Q1 MD&A MedMira FY2019 Q2 Financial Statements MedMira FY2019 Q2 MD&A MedMira FY2019 Q3 Financial Statements MedMira FY2019 Q3 MD&A MedMira FY2019 Financial Statements MedMira FY2019 MD&A MedMira 2019 Annual Report 2018 MedMira FY2018 Q1 Financial Statements MedMira FY2018 Q1 MD&A MedMira FY2018 Q2 Financial Statements MedMira FY2018 Q2 MD&A MedMira FY2018 Q3 Financial Statements MedMira FY2018 Q3 MD&A MedMira FY2018 Financial Statements MedMira FY2018 MD&A MedMira 2018 Annual Report 2017 MedMira FY2017 Q1 Financial Statements MedMira FY2017 Q1 MD&A MedMira FY2017 Q2 Financial Statements MedMira FY2017 Q2 MD&A MedMira FY2017 Q3 Financial Statements MedMira FY2017 Q3 MD&A MedMira FY2017 Financial Statements MedMira FY2017 MD&A MedMira 2017 Annual Report 2016 MedMira FY2016 Q1 Financial Statements MedMira FY2016 Q1 MD&A MedMira FY2016 Q2 Financial Statements MedMira FY2016 Q2 MD&A MedMira FY2016 Q3 Financial Statements MedMira FY2016 Q3 MD&A MedMira FY2016 Financial Statements MedMira FY2016 MD&A MedMira 2016 Annual Report Corporate Governance Dr. Hermes Chan Director Hermes Chan, President & Chief Executive Officer and Co-Founder, leads our passionate and committed team in driving the strategic direction and growth of MedMira. Hermes, who was named BioScience Innovator of the Year by The Economist in 2007, is the inventor of our patented rapid flow-through diagnostic technology platform. Since the company’s inception in 1994 Hermes has held progressively senior management roles including Research Scientist, General Manager, Senior Vice President, and Chief Operating Officer. Prior to creating MedMira, Hermes worked with another Canadian biotechnology company in the diagnostics research sector. Mr. Jianhe Mao Director Jianhe Mao is the owner of Unipec, a consulting firm based in St. Gallen, Switzerland. Unipec focuses on helping European companies enter the Chinese market, through operational restructuring and ownership and management optimization. In addition to leading Unipec, Mr. Mao is involved in several industrial projects and start-up ventures including Monsatec AG, a new company bridging the gap between laboratories and clinics with a cold plasma medical device. He serves on the boards of several European companies and is regarded as a trusted expert in legal cases, corporate corruption, operational turnarounds, and mergers and acquisitions. Mr. Mao began his career as a project engineer and has gained experience in business development and real estate investment. He holds M.E. from Ruhr University Bochum. Mr. Steven Cummings Director Mr. Steven Cummings is the Founder & President of Cambridge Financial Services, one of the leading full service accounting, tax, and business advisory firms in Nova Scotia. Under Mr. Cummings leadership, Cambridge Financial has earned an enviable reputation among businesses and industry for a commitment to high standards. Along with his leadership responsibilities at Cambridge Financial Services, Mr. Cummings was engaged as MedMira’s interim Chief Financial Officer in 2007. With more than 30 years of financial and entrepreneurial experience, Mr. Cummings is a frequent guest speaker on issues surrounding provincial taxation, taxation of seniors, and business ownership CONTACT US | LEGAL INFO | NEWS & EVENTS ©2020 MedMira Inc. All Rights Reserved. Follow us on